C4 Therapeutics, Inc(NASDAQ:CCCC) 
C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in pr...
Website: http://www.c4therapeutics.com
Founded: 2015
Full Time Employees: 88
CEO: Marc A. Cohen
Sector: Other
Industry: Other
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.35
H 1.36
L 1.27
C 1.31
V 1,125,016
10EMA 1.31
20EMA 1.31
60EMA 1.31
120EMA 1.31
250EMA 1.31